课题基金 / 基金详情

项目摘要

项目成果

DAVID Joseph SULLIVAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Iron supplementation in iron replete, but not iron deficient children has been shown to increase malaria associated morbidity. Iron chelators, while cytostatic for bacterial and mammalian cells, actually kill malaria parasites, despite the availability of millimolar heme iron in the infected erythrocyte. Iron repletion has not been fully evaluated in murine malaria models. The broad long term objective is to rapidly evaluate the type of iron supplementation and timing of malaria infection during iron repletion on malaria morbidity in mice with implications for human nutritional iron supplementation. We hypothesize that parasite bioavailable iron excess influences the hepatic stage significantly more than erythrocytic stage of malaria. The type of iron supplementation or timing of malaria infection during iron replenishment will alter malaria outcome possibly dependent on an iron effect on immune function rather than the erythrocyte iron level. The specific aims are 1) to compare the type of iron supplementation and timing of malaria infection in iron deficient and iron replete mice on both hepatic and erythrocytic stage malaria; 2) to evaluate the influence of iron supplementation and timing of malaria infection in genotypic iron defective mice for hepcidin or also erythroid, not hepatic, iron uptake and 3) to correlate malaria outcomes with hematologic biomarkers like hepcidin, erythrocyte ferritin and murine zinc protoporphyrin IX or immunologic biomarkers like interferon-gamma. The techniques to be utilized include mouse malaria testing, iron profiling and biomarker assays. These studies will be able to distinguish erythrocyte iron status from host immune response in malaria outcome with iron supplementation. The significant impact is to rapidly evaluate the method and type of iron therapy on malaria morbidity in mice with implications for human nutritional iron supplementation for children at risk of malaria. PUBLIC HEALTH RELEVANCE: This research will investigate the influence of iron supplementation in a mouse malaria model. The type of iron supplementation and timing of malaria infection during iron repletion on liver stage and blood cell stage malaria outcomes will be evaluated in iron deficient, iron replete and iron defective mice. Hematologic and immunologic biomarkers associated with outcome will be correlated
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nm.2368
发表时间: 2011-06
期刊: Nature medicine
影响因子: 82.9
作者: []
通讯作者:
Dual artemisinin action combats resistance
  • 批准号:
    10211154
  • 项目类别:
  • 资助金额:
    $58.54万
  • 财政年份:
    2021
  • 负责人:
    DAVID Joseph SULLIVAN
  • 依托单位:
Dual artemisinin action combats resistance
  • 批准号:
    10581538
  • 项目类别:
  • 资助金额:
    $56.94万
  • 财政年份:
    2021
  • 负责人:
    DAVID Joseph SULLIVAN
  • 依托单位:
Dual artemisinin action combats resistance
  • 批准号:
    10374922
  • 项目类别:
  • 资助金额:
    $56.94万
  • 财政年份:
    2021
  • 负责人:
    DAVID Joseph SULLIVAN
  • 依托单位:
Malaria and Mosquito-borne Diseases
  • 批准号:
    9792443
  • 项目类别:
  • 资助金额:
    $28.51万
  • 财政年份:
    2019
  • 负责人:
    DAVID Joseph SULLIVAN
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: